Inhibition of HIV-1 reverse transcriptase and protease by phlorotannins from the brown alga Ecklonia cava

被引:166
作者
Ahn, MJ
Yoon, KD
Min, SY
Lee, JS
Kim, JH
Kim, TG
Kim, SH
Kim, NG
Huh, H
Kim, J [1 ]
机构
[1] Seoul Natl Univ, Coll Pharm, Seoul 151742, South Korea
[2] Seoul Natl Univ, Pharmaceut Sci Res Inst, Seoul 151742, South Korea
[3] Kyung Hee Univ, East West Med Res Inst, Res Grp Pain & Neurosci Vis 2000 Project, Seoul 130701, South Korea
[4] Sungkyunkwan Univ, Inst Nat Sci, Dept Biol Sci, Suwon 440746, South Korea
[5] Korea Food & Drug Adm, Natl Inst Toxicol Res, Seoul 122020, South Korea
[6] Gyeongsang Natl Univ, Dept Aquaculture, Tongyoung 660701, South Korea
关键词
Ecklonia cava; 8,8 '-bieckol; 8,4 '''-dieckol; HIV-1 reverse transcriptase; noncompetitive inhibition; protease;
D O I
10.1248/bpb.27.544
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The bioassay-directed isolation of a marine brown alga, Ecklonia cava, afforded four phlorotannin derivatives, eckol (1), 8,8'-bieckol (2), 8,4"'-dieckol (3), and phlorofucofuroeckol A (4). Among these compounds, 2 and 3 exhibited an inhibitory effect on human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) and protease. Specifically, they inhibited the RT more potently than the protease. The inhibitory activity of compound 2 (IC50, 0.51 muM) against HIV-1 RT was comparable to that of nevirapine (IC50, 0.28 muM), a reference compound. An enzyme kinetic assay showed that this compound inhibited the RNA-dependent DNA synthesis activity of HIV-1 RT noncompetitively against dUTP/dTTP with a K-i value of 0.78 muM. With respect to the homopolymeric template/primer, (rA)(n)(dT)(15), 8,8'-bieckol (2) displayed an uncompetitive type of inhibition (K-i, 0.23 muM).
引用
收藏
页码:544 / 547
页数:4
相关论文
共 24 条
[1]   Inhibition of HIV-1 reverse transcriptase and HIV-1 integrase and antiviral activity of Korean seaweed extracts [J].
Ahn, MJ ;
Yoon, KD ;
Kim, CY ;
Min, SY ;
Kim, YU ;
Kim, HJ ;
Kim, JH ;
Shin, CG ;
Lee, CK ;
Kim, TG ;
Kim, SH ;
Huh, H ;
Kim, J .
JOURNAL OF APPLIED PHYCOLOGY, 2002, 14 (05) :325-329
[2]  
CARROLL SS, 1993, J BIOL CHEM, V268, P276
[3]  
De Clercq E, 2000, MED RES REV, V20, P323, DOI 10.1002/1098-1128(200009)20:5<323::AID-MED1>3.0.CO
[4]  
2-A
[5]  
DEBYSER Z, 1992, MOL PHARMACOL, V41, P963
[6]   HIV INHIBITORS TARGETED AT THE REVERSE-TRANSCRIPTASE [J].
DECLERCQ, E .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1992, 8 (02) :119-137
[7]  
FRANK KB, 1991, J BIOL CHEM, V266, P19232
[8]  
FUKUYAMA Y, 1990, CHEM PHARM BULL, V38, P133
[9]  
FUKUYAMA Y, 1989, CHEM PHARM BULL, V37, P2438, DOI 10.1248/cpb.37.2438
[10]  
FUKUYAMA Y, 1995, CHEM LETT, P739